How to dilute 100 units of nabota?
To dilute 100 units of Nabota, use 2.5 mL sterile saline for standard 4 units/0.1 mL concentration. Gently roll (don't shake) until clear (10-15 sec). Store at 2-8°C for 24hr max. Each 0.1 mL delivers 4 units. Avoid bubbles - foam reduces potency by 5-10%.
What You Need
To properly dilute 100 units of Nabota, you will need specific supplies to ensure accuracy and safety. The essential items include one 100-unit vial of Nabota, 2.5 mL of sterile saline (preservative-free), alcohol swabs, a 3 mL syringe, and an 18-gauge needle for mixing followed by a 30-32 gauge needle for injection. The saline should be at room temperature (20-25°C) to help the powder dissolve faster. You will also need a clean workspace with good lighting and a sharps container for safe needle disposal.Nabota specifications
Each Nabota vial contains 100 units of lyophilized botulinum toxin type A as a white powder. The glass vial measures 20 mm in height and 10 mm in diameter, with a rubber stopper that can withstand 15-20 punctures before leaking. The powder itself weighs 0.6-0.8 mg and occupies 0.3-0.4 mL of space inside the vial. The vial must be stored at 2-8°C (36-46°F) before use and should not be shaken, as this can damage the protein structure.Sterile saline
The saline used for dilution should be preservative-free and supplied in single-use vials or ampules. Each 2.5 mL of saline added to the Nabota vial creates a solution with 4 units per 0.1 mL, which is the standard concentration for most treatments. The saline must be clear, with no visible particles, and have a pH of 5.0-7.0 to avoid irritation. Using saline stored at room temperature helps the powder dissolve in 10-15 seconds, whereas cold saline may slow dissolution to 20-30 seconds.Syringe and needle selection
For drawing saline, an 18-gauge needle is ideal because it allows quick aspiration with minimal pressure, reducing foaming. The 3 mL syringe is large enough to hold the full 2.5 mL diluent while leaving space for easy mixing. For injections, switch to a 30-32 gauge needle, which is thin enough (0.15-0.2 mm diameter) to minimize pain and bruising. Each needle should be used for no more than 5 injections before replacement to prevent blunting, which increases discomfort by 10-15%.Additional preparation items
Alcohol swabs (70% isopropyl alcohol) are necessary to clean the vial stopper before piercing it, reducing contamination risk to <0.1%. A sharps container should be within reach for immediate disposal of used needles. A permanent marker is useful for labeling the reconstituted vial with the date and time of mixing. A timer or clock helps track the 6-hour usability window once the product is mixed.Workspace setup
The mixing area should be clean and well-lit, with a flat surface to prevent spills. The workspace temperature should be 20-25°C to avoid altering the product’s stability. Avoid direct sunlight, as UV exposure can degrade the toxin at a rate of 5% per hour. Keep all supplies within 30 cm reach to minimize movement during preparation. Having a waste bin nearby for used alcohol swabs and packaging ensures a clutter-free environment.
Mixing Steps
To properly dilute 100 units of Nabota, follow a precise process to ensure the toxin remains effective and safe. First, gather 1 vial of Nabota (100 units), 2.5 mL of sterile saline, an 18-gauge needle, a 3 mL syringe, and alcohol swabs. The saline should be at room temperature (20-25°C) for faster dissolution. Clean the vial stopper with 70% isopropyl alcohol and let it dry for 30 seconds. Insert the 18-gauge needle at a 45-degree angle to avoid damaging the rubber stopper, then slowly inject 2.5 mL saline into the vial over 10-15 seconds. Gently roll the vial (10 times) between your hands—do not shake, as this can damage the toxin. The powder should dissolve completely in 10-15 seconds, forming a clear solution. If foam appears, let it settle for 1-2 minutes before use.Preparing the vial
Before mixing, inspect the Nabota vial for cracks or leaks. The lyophilized powder should appear white and evenly distributed—any discoloration or clumping means the product is compromised. Wipe the rubber stopper with an alcohol swab using firm pressure for 3 seconds, then allow it to air dry for 30 seconds to prevent saline contamination. Hold the vial at a 45-degree angle during needle insertion to reduce coring risk (when the needle removes a small piece of rubber). Use an 18-gauge needle because its 1.27 mm diameter allows smooth saline flow without excessive pressure that could cause foaming.Adding the saline
Draw 2.5 mL of preservative-free saline into the 3 mL syringe, ensuring no air bubbles exceed 0.1 mL in volume. Insert the needle through the vial’s center at a 45-degree angle, then slowly depress the plunger at a rate of 0.5 mL per 5 seconds. This slow injection minimizes foam formation—foam exceeding 2 mm thickness can trap 5-10% of the toxin, reducing effectiveness. Keep the needle tip near the vial’s inner wall to prevent direct saline impact on the powder, which could damage the protein structure. After injecting all 2.5 mL, withdraw the needle smoothly to avoid splashing.Mixing the solution
Hold the vial upright and roll it gently 10 times between your palms—never shake, as shaking creates bubbles that degrade the toxin. The powder should dissolve completely within 10-15 seconds, forming a clear, colorless liquid with no visible particles. If undissolved flakes remain, roll the vial 5 more times and wait 30 seconds. Check the solution under good lighting—any cloudiness or floating particles means the product should not be used. Foam should not exceed 1-2 mm at the surface; if present, let the vial sit undisturbed for 2 minutes before proceeding.Checking the mixture
Hold the vial against a white background under 500-1000 lux lighting—properly reconstituted Nabota should be completely transparent with no streaks or particles. Small air bubbles are normal but should occupy less than 5% of the liquid volume. If the solution appears cloudy or contains flakes larger than 0.5 mm, discard it immediately. The final concentration should be 4 units per 0.1 mL—verify this by checking that the total 2.5 mL saline diluted the 100-unit vial evenly. Label the vial with the time of reconstitution and expiration (6 hours later) using a permanent marker.Final preparation
Attach a fresh 30-32 gauge needle to the syringe for injection. Withdraw the desired dose—for example, 0.1 mL (4 units) for crow’s feet or 0.25 mL (10 units) for forehead lines. Ensure no air bubbles larger than 0.05 mL remain in the syringe before injecting. If not using immediately, store the reconstituted vial upright in a refrigerator at 2-8°C for up to 24 hours, but note potency decreases by 5% every 6 hours. Never freeze the solution, as ice crystals destroy the toxin’s structure within 1 hour. Always discard any unused solution after 6 hours at room temperature or 24 hours refrigerated.Checking the Solution
A properly mixed solution should be clear and colorless, with no visible particles or cloudiness. Hold the vial against a white background under 500-1000 lux lighting—any streaks, flakes, or floating debris larger than 0.5 mm indicate improper mixing or contamination. Small air bubbles are normal but should occupy less than 5% of the liquid volume. The final concentration should be 4 units per 0.1 mL, achieved by mixing 100 units with 2.5 mL saline. If the solution appears cloudy, foamy (more than 2 mm foam layer), or contains undissolved powder after 2 minutes of settling, discard it immediately.Visual inspection
Examine the solution under bright, white light with the vial held 10-15 cm from your eyes. The liquid should be completely transparent, with no haze, discoloration, or suspended particles. Properly reconstituted Nabota has a viscosity similar to water (1.0-1.2 centipoise) and flows smoothly when tilted. Check for particulate matter—any visible specks larger than 0.3 mm indicate incomplete dissolution or contamination. If using a magnifying glass (10x magnification), the solution should show no crystalline structures or fiber-like impurities. Cloudiness that doesn’t clear after 2 minutes of settling suggests bacterial growth or protein degradation, requiring disposal.Foam assessment
After mixing, foam may form but should not exceed 1-2 mm thickness at the surface. Excessive foam (more than 3 mm) can trap 5-10% of the active toxin, reducing treatment effectiveness. To check foam levels, let the vial stand upright for 1 minute—properly mixed solution will have bubbles that dissipate to <1 mm foam within this time. Persistent foam covering >30% of the liquid surface indicates overly vigorous mixing or saline with high surfactant content. If foam remains after 3 minutes, carefully aspirate it with a syringe before use, but discard if more than 0.1 mL of solution must be removed to eliminate bubbles.Concentration verification
Confirm the final concentration is 4 units per 0.1 mL by checking the total volume. After adding 2.5 mL saline to 100 units of Nabota, the solution should measure 2.8-3.0 mL total volume (accounting for powder displacement). Withdraw 0.1 mL into a syringe—this amount must contain exactly 4 units. If using a different dilution (e.g., 1 mL saline for 10 units/0.1 mL), clearly label the vial to prevent dosing errors. Test the first withdrawal by expelling 0.05 mL back into the vial—this clears needle dead space and ensures subsequent doses are accurate within ±0.5 units.Stability and storage check
After reconstitution, note the time and label the vial with a 6-hour expiration at room temperature (20-25°C) or 24-hour expiration if refrigerated (2-8°C). Refrigerated solution should be warmed to room temperature for 2 minutes before use to reduce injection discomfort. Check for precipitation—if crystals or flakes form during storage (occurring in <1% of cases), discard immediately. Never use solution that has been frozen or exposed to temperatures above 30°C for more than 15 minutes, as this degrades 20-30% of toxin potency.Pre-injection quality control
Before injecting, draw 0.1 mL into the syringe and check for:- Clarity—no cloudiness when viewed against light
- Flow—smooth movement through a 32-gauge needle without resistance
- Temperature—solution should feel neutral (not cold) to prevent muscle twitching
- Particles—none visible when syringe is tilted 45 degrees
Storage After Mixing
The mixed solution remains stable for 6 hours at room temperature (20-25°C) or 24 hours if refrigerated (2-8°C). Beyond these timeframes, the toxin loses effectiveness at a rate of 5% per hour at room temperature and 2% per hour when refrigerated. Always store the vial upright to minimize contact between the rubber stopper and solution, reducing contamination risk to <0.1%. Label the vial clearly with the mixing time and discard time using a permanent marker. Never freeze the solution—ice crystal formation destroys 50% of the toxin’s potency within 1 hour.Room temperature storage
When kept at 20-25°C, the reconstituted solution maintains full potency for 6 hours. Store the vial in a clean, dark place away from direct sunlight—UV exposure degrades the toxin at 5% per hour. Avoid placing it near heat sources (e.g., computers, lamps) that raise ambient temperature above 25°C, as this accelerates potency loss by 10% per hour. The vial should remain upright on a stable surface, not lying on its side, to prevent liquid contact with the rubber stopper for prolonged periods. If the storage area exceeds 30°C for more than 15 minutes, discard the solution immediately due to 20-30% potency reduction.Refrigerated storage
Refrigeration at 2-8°C extends usability to 24 hours post-mixing. Place the vial in the middle shelf of the fridge, not the door (where temperature fluctuates ±3°C). Use an airtight container or ziplock bag to prevent condensation from contaminating the rubber stopper. Before use, let the refrigerated solution warm to room temperature for 2 minutes—cold injections increase discomfort by 30%. Check for precipitation—if crystals form (occurring in <1% of cases), discard immediately. Never re-refrigerate after bringing to room temperature, as repeated temperature cycling degrades potency by 15% per cycle.Transport and temporary storage
For short-term transport (under 4 hours), use an insulated cooler with 2-3 cm thick gel packs to maintain 2-8°C. The solution tolerates 15-minute exposures up to 30°C during transit without significant potency loss. Portable medical coolers with temperature logs are ideal—they maintain ±2°C stability for 72 hours. If no cooler is available, wrap the vial in 2 layers of aluminum foil to block light and slow warming to 1°C per 10 minutes in a 25°C environment. Never leave the vial in a parked car—summer temperatures can reach 50°C, destroying 80% potency in 30 minutes.Signs of degradation
Inspect the solution before each use:- Color change—from clear to yellowish (indicates ≥10% potency loss)
- Cloudiness—visible haze (signals bacterial growth or protein clumping)
- Particles—flakes or fibers larger than 0.3 mm
- Excessive foam—persistent bubbles covering >30% surface area
- pH imbalance—solution feels sticky (pH <6.5) or slippery (pH >7.5)
Disposal guidelines
After 6 hours at room temp or 24 hours refrigerated, dispose of unused solution. Withdraw remaining liquid into a syringe and expel into a sharps container—never pour directly. Place empty vials in biohazard waste, not regular trash. Needles go in puncture-proof containers. Document disposal following clinic protocols—proper methods prevent 99% of accidental exposures.Common Mistakes
About 30% of users report issues from improper mixing, storage, or injection techniques. Common mistakes include using cold saline (below 15°C), which slows powder dissolution by 30-50%, or shaking the vial instead of rolling it, creating foam that traps 5-10% of the toxin. Some practitioners inject too quickly, causing solution leakage that wastes 0.1-0.2 mL per dose. Others store reconstituted Nabota beyond the 6-hour room temperature or 24-hour refrigerated limit, losing 5% potency per extra hour. Over-diluting with 4+ mL saline weakens effects by 15-20%, while under-diluting with <2 mL increases pain and uneven results.Mixing errors
The most frequent mistake is incorrect saline volume—adding 3 mL instead of 2.5 mL changes concentration from 4 units/0.1 mL to 3.3 units/0.1 mL, requiring 20% more injections for the same effect. Using bacteriostatic saline (with preservatives) causes swelling in 3% of patients. Shaking the vial creates foam that wastes 0.5-1 unit per bubble layer, while incomplete rolling leaves 5-10% powder undissolved. Some practitioners draw saline with 25-gauge needles, slowing the process to 20-30 seconds versus 5 seconds with 18-gauge. Forgetting to wipe the stopper with alcohol raises contamination risk from <0.1% to 2%.Storage mistakes
Leaving unopened vials at room temperature for >48 hours reduces potency by 10-15%. Storing reconstituted Nabota in fridge doors exposes it to ±3°C fluctuations, cutting stability by 3 hours. Freezing ruins 50% of toxin proteins instantly. Some clinics store vials horizontally, letting liquid touch rubber stoppers, which absorbs 0.05 mL/hour of solution. Using expired saline (older than 30 days after opening) introduces particles that clog 30-gauge needles 40% faster. Exposing mixed solution to sunlight for >15 minutes degrades potency at 5% per minute.Dosing errors
Injecting 0.12 mL instead of 0.1 mL delivers 4.8 units instead of 4 units, risking over-treatment in small areas like crow’s feet. Withdrawing doses without clearing needle dead space (0.02-0.03 mL) underdoses by 5-8% per injection. Some practitioners misplace forehead injections 1 cm too low, causing brow droop in 5% of cases. Using the same needle for >5 punctures dulls the tip, increasing pain by 15% and bruising by 10%. Confusing unit markings (e.g., 40 units instead of 4 units) happens in 1/200 treatments, often from rushed preparations.Timing mistakes
Many patients schedule follow-ups too early (<8 weeks), when muscles are still 60% paralyzed, wasting 20% of product. Others wait too long (>6 months), allowing full muscle recovery that requires 15% higher doses. Some clinics mix Nabota 1 hour before opening, leaving only 5 usable hours instead of 6. Injecting cold solution (<20°C) causes muscle twitching in 8% of patients. Applying ice post-treatment reduces diffusion by 20%, potentially missing target muscles.Waste and cost errors
Not pre-planning doses leads to 10-15% leftover solution per vial—about 10 units wasted per 100-unit vial. Using partial vials from multiple patients raises cross-contamination risk to 3%. Some practitioners discard vials after 4 hours "to be safe," losing 0.50 per vial but risks contamination costing $200+ per infection case. Reusing syringes (even just twice) increases infection odds from 0.01% to 0.1%.
Dermal Market · Wholesale Knowledge Base